130 related articles for article (PubMed ID: 5332263)
1. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
Engström J
Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
[No Abstract] [Full Text] [Related]
2. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
3. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
4. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
5. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
6. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
7. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
Barnett AJ; Carson V
Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
[No Abstract] [Full Text] [Related]
8. A three-year trial of atromid therapy in exudative diabetic retinopathy.
Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
[No Abstract] [Full Text] [Related]
9. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
10. [Effect of Atromid on blood lipids in patients with hyperlipemia].
Baranova LV
Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
[No Abstract] [Full Text] [Related]
11. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
12. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
Cullen JF; Ireland JT; Oliver MF
Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
[No Abstract] [Full Text] [Related]
13. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
[No Abstract] [Full Text] [Related]
14. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
15. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
Warembourg H; Jaillard J
Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
[No Abstract] [Full Text] [Related]
16. Divergent effects in the treatment of hyperlipemia.
Slowe IA; Carter AC; Feldman EB
Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
[No Abstract] [Full Text] [Related]
17. Ethyl chlorophenoxyisobutyrate (CPIB) effects in juvenile-onset diabetes mellitus.
Danowski TS; Cohn RE; Limaye NR; Novak JF; Saul R; Sunder JH; Moses C
Clin Pharmacol Ther; 1965; 6(6):716-30. PubMed ID: 5321221
[No Abstract] [Full Text] [Related]
18. Atromid and platelet adhesiveness in multiple sclerosis.
Millac P; Caspary EA; Prineas J
J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
[No Abstract] [Full Text] [Related]
19. Laboratory indices in clofibrate therapy of juvenile-onset diabetes.
Narduzzi JV; Danowski TS; Weir TF; Alley RA; Vester JW; Moses C
Clin Pharmacol Ther; 1967; 8(6):817-23. PubMed ID: 4862480
[No Abstract] [Full Text] [Related]
20. Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia.
Scott PJ; Hurley PJ
J Atheroscler Res; 1969; 9(1):25-34. PubMed ID: 5779579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
